BFA
REGN icon

BlackRock Fund Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

BlackRock Fund Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$898M Buy
2,447,609
+157,214
+7% +$59.8M 0.17% 90
2016
Q3 		$921M Buy
2,290,395
+68,436
+3% +$27.5M 0.19% 84
2016
Q2 		$776M Buy
2,221,959
+13,282
+0.6% +$5.12M 0.17% 96
2016
Q1 		$796M Buy
2,208,677
+113,864
+5% +$46.9M 0.18% 85
2015
Q4 		$1.14B Sell
2,094,813
-192,163
-8% -$104M 0.26% 58
2015
Q3 		$1.06B Buy
2,286,976
+167,718
+8% +$90.1M 0.28% 53
2015
Q2 		$1.08B Buy
2,119,258
+58,979
+3% +$28.8M 0.26% 55
2015
Q1 		$930M Buy
2,060,279
+114,662
+6% +$48.6M 0.22% 61
2014
Q4 		$798M Buy
1,945,617
+40,580
+2% +$16M 0.2% 70
2014
Q3 		$687M Buy
1,905,037
+448,225
+31% +$150M 0.19% 69
2014
Q2 		$412M Sell
1,456,812
-41,473
-3% -$12.3M 0.12% 153
2014
Q1 		$450M Sell
1,498,285
-348,819
-19% -$107M 0.13% 119
2013
Q4 		$508M Buy
1,847,104
+112,631
+6% +$32.4M 0.15% 95
2013
Q3 		$543M Buy
1,734,473
+215,249
+14% +$56.6M 0.18% 78
2013
Q2 		$342M Buy
+1,519,224
New +$354M 0.13% 131

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

BlackRock Fund Advisors's REGN Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Regeneron Pharmaceuticals (REGN) stake by 6.9% in Q4 2016, buying an estimated $59.8M and bringing the position to 2,447,609 shares worth $898M. The position accounts for 0.17% of the portfolio, ranked #90.

BlackRock Fund Advisors first reported a position in REGN in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.14B in Q4 2015. 576 funds tracked by Wall St. Rank hold REGN as of Q4 2016.

  • BlackRock Fund Advisors held 2,447,609 shares of Regeneron Pharmaceuticals worth $898M as of Q4 2016.
  • BlackRock Fund Advisors bought 157,214 Regeneron Pharmaceuticals shares in Q4 2016, an estimated $59.8M.
  • Regeneron Pharmaceuticals made up 0.17% of BlackRock Fund Advisors's portfolio in Q4 2016, its #90 holding.
  • BlackRock Fund Advisors first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Regeneron Pharmaceuticals position peaked at $1.14B in Q4 2015.
  • 576 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.